264 Million Reasons Psychedelic Stocks Have More Room to Grow
11 févr. 2021 08h30 HE
|
OTC Stock Review
ATLANTA, Feb. 11, 2021 (GLOBE NEWSWIRE) -- OTC Stock Review: Unless you have been hiding under a rock for the last year, you probably know psychedelic stocks have been among the biggest movers on...
Mycotopia Therapies (20/20 Global) to Launch PsyBioMed, a Biosynthetic Compound, a Biotech Company for the Global Production of Psychedelics
08 févr. 2021 08h30 HE
|
20/20 Global, Inc.
MIAMI, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies (20/20 Global, Inc.), (OTC Pink: TWGL), a company focused on psychedelic therapies, is establishing a biosynthetic compound subsidiary...
20/20 Global Announces It Has Applied for a Name and Stock Symbol Change with FINRA
08 févr. 2021 08h00 HE
|
20/20 Global, Inc.
MIAMI, Feb. 08, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc., (OTC Pink: TWGL) “Mycotopia”, a company focused on psychedelic therapies, announced today that it has applied to the Financial Industry...
Ehave Couples KetaDASH with Digital Therapeutics Expertise to Combat Clinical Depression
01 févr. 2021 08h30 HE
|
Ehave
MIAMI, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, is announcing plans to roll...
Ehave Looks to Expand KetaDASH to Palliative Care
27 janv. 2021 08h30 HE
|
Ehave
MIAMI, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it is...
20/20 Global, Inc. PsyTech the World’s Most Recognized Psychedelic Conference to Host Live Webinar on New Approaches to Ketamine-Assisted Treatment Wednesday, January 27th 2021 at 12:00 EST
26 janv. 2021 08h30 HE
|
20/20 Global, Inc.
MIAMI, Jan. 26, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc., (OTC Pink: TWGL) (the “Company”) announced today an upcoming complimentary Psychedelic Industry webinar for investors and interested...
4 Top Stocks for Huge Gains from the Psychedelic Renaissance
25 janv. 2021 08h30 HE
|
OTC Stock Review
ATLANTA, Jan. 25, 2021 (GLOBE NEWSWIRE) -- OTC Stock Review was early to the party with an article on Seeking Alpha March 6, 2020 titled "Psychedelic Medicine Stocks Capture the Attention of...
Ehave, Inc. Utilizes Artificial Intelligence and Machine Learning for Big Data Management in Mental Healthcare
25 janv. 2021 08h30 HE
|
Ehave
MIAMI, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today plans to...
Ehave Closes Transaction to Acquire CureDash Assets, Adds KetaDASH Home Delivery Service for Ketamine Clinics
22 janv. 2021 08h30 HE
|
Ehave
MIAMI, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it completed...
Ehave Revolutionizes Patient Medical Records for Psychedelic Mental Health
21 janv. 2021 08h51 HE
|
Ehave
Medical records platform for psychedelic mental health to be available February 1 as a Plugin to the Ehave Dashboard. MIAMI, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the...